Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products... Show more
Nature's Sunshine Products, Inc. (NATR) operates in the global natural health and wellness space, manufacturing and selling nutritional supplements and personal-care products under its namesake brand and the Synergy WorldWide brand across more than 40 countries. The company has historically relied on a consultant-led direct-selling model, but its forward-looking market positioning increasingly depends on a hybrid strategy that layers a fast-growing digital, subscription-based channel on top of that legacy network.
A key structural advantage is vertical integration: the company manufactures more than 90% of its products internally, giving it control over quality, sourcing, and cost. That foundation has supported gross margins in the low-70% range, with management signaling further modest improvement. Meanwhile, subscription auto-ship programs are building recurring revenue, particularly in Japan and China, which reduces the volatility typically associated with one-off direct-selling promotions.
The competitive risk is that Nature's Sunshine is a relatively small player in a fragmented supplement market dominated by larger consumer-staples and e-commerce brands. Its medium-term positioning will depend on whether digital customer acquisition can scale profitably without undermining the consultant network — a channel-conflict risk management has acknowledged and is addressing through differentiated product lines.
Several forward-looking catalysts could shape investor sentiment for NATR. First, continued execution of the digital transformation is pivotal. New digital customers grew sharply, and management has indicated it will keep investing in digital advertising as long as customer-acquisition economics remain favorable. Sustained gains here would validate the strategy's unit economics.
Second, geographic expansion is a tangible growth lever. The company recently entered Germany, Europe's largest supplement and direct-selling market, and has signaled plans to enter an additional Asian market pending regulatory approval. Deeper penetration into cities beyond Tokyo and Seoul also represents incremental revenue opportunity.
Third, product innovation is broadening the addressable market. Nature's Sunshine is developing supplements designed to support consumers using GLP-1 (glucagon-like peptide-1) weight-loss therapies, alongside a focus on digestive health, women's health, and Asian skincare. These categories align with long-term consumer-demand trends.
On the analyst front, consensus recommendations remain favorable — widely cited data indicates a "strong buy" posture with an average 12-month price target around $30.50, against a range of roughly $25 to $36. However, recent revisions have been mixed: one firm lowered its target while another maintained a higher one, suggesting that optimism about growth is tempered by concern over macro conditions and near-term execution. Upcoming earnings reports, new market launches, and any M&A announcements are the events most likely to shift that balance.
Nature's Sunshine's trajectory is closely tied to global consumer demand for preventive health and wellness products, a category with structural tailwinds from aging populations and rising health consciousness. At the same time, the company is highly exposed to discretionary-spending cycles in its consumer base, which can fluctuate with inflation and employment conditions.
Interest rates and currency movements matter directly. A meaningful share of revenue is generated internationally, particularly in Asia and Europe, so foreign-exchange swings can distort reported growth even when local-currency demand is solid. Tariffs and raw-material inflation are additional margin sensitivities; management has explicitly flagged these as uncertainties embedded in its wider-than-usual guidance range.
Regulatory and geopolitical factors also play a role. Direct selling is subject to varying rules across jurisdictions, and the company's Eastern European operations operate near a region affected by ongoing conflict. Any escalation or economic instability could dampen consultant activity and consumer demand in those markets.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool designed to help traders assess whether a stock, ETF (exchange-traded fund), or other asset may trend bullish, bearish, or sideways over the next week or month. It is built to support users in identifying developing trends, evaluating possible breakouts or reversals, and exploring predictions across a broad range of tradable instruments. The platform includes searchable prediction categories, historical context, and alert-oriented functionality to keep users informed as conditions evolve. For those seeking a data-driven complement to fundamental analysis of tickers such as NATR, the Trend Prediction Engine offers a practical way to monitor directional signals.
Looking ahead to 2026 and beyond, the central question for NATR is whether its digital and subscription momentum can convert a historically modest growth rate into a durable, higher-growth trajectory. Management's 2026 guidance calls for revenue of approximately $500 million to $515 million and adjusted EBITDA of $50 million to $54 million, reflecting mid-single-digit top-line growth with continued margin discipline.
Longer term, the $1 billion revenue ambition rests on several structural drivers: deeper digital penetration across all regions, expansion into new geographies and channels, product innovation tied to fast-growing wellness themes, and selective bolt-on acquisitions. A new chief financial officer joining leadership brings additional strategic and capital-allocation experience, which could influence the pace and shape of these initiatives.
The primary risks to this outlook are margin sustainability amid tariff and inflationary pressure, the inherent lumpiness of APAC demand, potential channel conflict between digital and consultant-led sales, and execution risk in newly entered markets. Consensus analyst expectations remain generally constructive, but price targets have shown mixed recent revisions, underscoring that the market is weighing an attractive long-term growth story against nearer-term macro uncertainty.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EMMF | 36.03 | 0.34 | +0.96% |
| WisdomTree Emerging Markets Multifactor Fund (EMMF) | |||
| FEBU | 30.09 | 0.07 | +0.25% |
| AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF (FEBU) | |||
| PMJN | 27.06 | 0.04 | +0.13% |
| PGIM S&P 500 Max Buffer ETF - June (PMJN) | |||
| SHLD | 61.31 | -0.17 | -0.28% |
| Global X Defense Tech ETF (SHLD) | |||
| GXUS | 61.20 | -0.45 | -0.72% |
| Goldman Sachs MarketBeta Total International Equity ETF (GXUS) | |||
A.I.dvisor tells us that NATR and BGS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NATR and BGS's prices will move in lockstep.
| Ticker / NAME | Correlation To NATR | 1D Price Change % | ||
|---|---|---|---|---|
| NATR | 100% | -0.71% | ||
| BGS - NATR | 28% Poorly correlated | -3.93% | ||
| JBSS - NATR | 28% Poorly correlated | -1.54% | ||
| CENTA - NATR | 27% Poorly correlated | -1.16% | ||
| LSF - NATR | 25% Poorly correlated | +7.28% | ||
| CENT - NATR | 25% Poorly correlated | -1.09% | ||
More | ||||
| Ticker / NAME | Correlation To NATR | 1D Price Change % |
|---|---|---|
| NATR | 100% | -0.71% |
| Food: Major Diversified industry (63 stocks) | -5% Poorly correlated | +1.05% |
a manufacturer of nutritional and personal care products
Industry FoodMajorDiversified
The RSI Oscillator for NATR moved out of oversold territory on October 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In 20 of the 27 cases the stock moved higher. This puts the odds of a move higher at 74%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 42 of 60 cases where NATR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on NATR as a result. In 67 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
Following a +0.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where NATR advanced for three days, in 171 of 246 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
NATR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NATR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
The Aroon Indicator for NATR entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.304) is normal, around the industry mean (1.813). P/E Ratio (12.304) is within average values for comparable stocks, (6.359). Projected Growth (PEG Ratio) (1.999) is also within normal values, averaging (8.458). NATR's Dividend Yield (0.319) is considerably higher than the industry average of (0.054). P/S Ratio (0.480) is also within normal values, averaging (4.925).
The Tickeron Seasonality Score of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating fairly steady price growth. NATR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 67 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NATR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.